The guinea-pig oesophagus is a versatile in vitro preparation for pharmacological studies

Clinical and Experimental Pharmacology and Physiology

Volumn 29, Issue 12, 2002, Pages 1047-1054

  Kerr, Karen P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Ganglionic blockers; Guinea pigs; Histology; Muscle contraction; Myenteric plexus; Neuromuscular non depolarizing agents; Oesophagus; Skeletal muscle; Smooth muscle; Vagus nerve

Indexed keywords

ACETYLCHOLINE; ATROPINE; BETA BUNGAROTOXIN; CALCITONIN GENE RELATED PEPTIDE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CHOLINERGIC RECEPTOR; COCAINE; HEXAMETHONIUM; MUSCLE RELAXANT AGENT; NEUROTOXIN; OMEGA CONOTOXIN GVIA; SEROTONIN; SNAKE VENOM; SUBSTANCE P; TACHYKININ RECEPTOR; TETRODOTOXIN; TRIMETAPHAN; TUBOCURARINE CHLORIDE; VASOACTIVE INTESTINAL POLYPEPTIDE; VENOM ANTISERUM;

EFFERENT NERVE; ESOPHAGUS MUCOSA; ESOPHAGUS MUSCLE; GANGLION BLOCK; GUINEA PIG; IN VITRO STUDY; MUSCLE INNERVATION; MYENTERIC PLEXUS; NERVE ENDING; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; REVIEW; SENSORY NERVE CELL; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER; SYNAPSE; VAGUS NERVE;

ANIMALS; ESOPHAGUS; GUINEA PIGS; HUMANS; PHARMACEUTICAL PREPARATIONS; VAGUS NERVE;

EID: 0036034850     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2002.03774.x     Document Type: Review

References (55)

1. Ingelfinger FJ. Oesophageal motility. Physiol. Rev. 1958; 38: 553-84.
2. Beveridge AA, Taylor GS. Comparison of nervous control of smooth and skeletal muscle. Proc. Aust. Physiol. Pharmacol. Soc. 1987; 18: 203-10.
3. Kerr KP, Stevenson JE, Mitchelson F. Simultaneous comparison of nicotinic receptor antagonists on three nicotinic acetylcholine receptors. J. Pharm. Pharmacol. 1995; 47: 1002-6.
4. Hunter JM. New neuromuscular blocking drugs. N. Engl. J. Med. 1995; 332: 1691-9.
5. Vizi ES, Lendvai B. Side effects of nondepolarising muscle relaxants: Relationship to their antinicotinic and antimuscarinic actions. Pharmacol. Ther. 1997; 73: 75-89.
6. Lee CY. Recent advances in chemistry and pharmacology of snake toxins. In: Ceccarelli B, Clementi F (eds). Advances in Cytopharmacology, Vol. 3. Raven Press, New York. 1979; 1-16.
7. Chiappinelli VA. κ-Neurotoxins and α-neurotoxins: Effects on neuronal nicotinic acetylcholine receptors. In: Harvey AL (ed.). International Encylopedia of Pharmacology and Therapeutics, Section 134, Snake Toxins. Pergamon Press, New York. 1991; Ch. 6.
8. Bartlet AL. The effect of vagal stimulation and eserine on isolated guinea-pig oesophagus. Q. J. Exp. Physiol. 1968; 53: 170-4.
9. Akbarali HI, Bieger D, Triggle CR. Tetrodotoxin-sensitive and -insensitive relaxations in the rat oesophageal tunica muscularis mucosae. J. Physiol. 1986; 381: 49-63.
10. Bieger D, Triggle C. Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation. Br. J. Pharmacol. 1985; 84: 93-106.
11. Bieger D, Marsh DC. Substance P modulates vagal cholinergic transmission in rat oesophageal striated and smooth muscle. Eur. J. Pharmacol. 1990; 183: 2045.
12. Maggi CA, Patacchini R, Rovero P, Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J. Auton. Pharmacol. 1993; 13: 23-93.
13. 3 receptor. Life Sci. 1995; 56: PL27-32.
14. Wheater PR, Burkitt HG, Daniels VG. Functional Histology. A Text and Colour Atlas. Churchill Livingstone, Edinburgh. 1979.
15. Whitmore I. Oesophageal striated muscle arrangement and histochemical fibre types in guinea-pig, marmoset, macaque and man. J. Anat. 1982; 134: 685-95.
16. Thomas GA, Trounce JR. The effect of neuromuscular and ganglion blockade on the function of the guinea-pig oesophagus. Guy's Hosp. Rep. 1960; 109: 21-8.
17. Bartlet AL. Actions of 5-hydroxytryptamine and histamine on the neural structures and muscularis mucosae of the guinea-pig oesophagus. Br. J. Pharmacol. Chemother. 1968; 33: 184-92.
18. Irwin DA. The anatomy of Auerbach's plexus. Am. J. Anat. 1931; 49: 141-66.
19. Doty RW. Neural organization of deglutition. In: Code CF, Heidel W (eds). Handbook of Physiology, Section 6: Alimentary Canal, Vol. IV. American Physiological Society, Washington DC. 1968; Ch. 92.
20. Goyal RK, Paterson WG. Esophageal motility. In: Schultz SG, Wood JD, Rauner BB (eds). Handbook of Physiology, Section 6: The Gastrointestinal System, Vol. 1, Part 2. American Physiological Society, Bethesda. 1989; Ch. 22.
21. Biancani P, Behar J. Esophageal motor function. In: Yamada T (ed.). Textbook of Gastroenterology, Vol. I. JB Lippincott, Philadelphia. 1991; Ch. 7.
22. Morikawa S, Komuro T. Ultrastructure of intramural ganglia in the striated muscle portions of the guinea-pig oesophagus. J. Anat. 1999; 195: 111-20.
23. Christensen J. Pharmacology of the oesophageal motor function. Annu. Rev. Pharmacol. 1975; 15: 243-58.
24. Beveridge AA, Taylor GS. Evidence for a lower oesophageal sphincter in the guinea-pig. Comp. Biochem. Physiol. C. 1989; 93: 293-301.
25. Kamikawa Y, Shimo Y. Cholinergic and adrenergic innervations of the muscularis mucosae in guinea-pig esophagus. Arch. Int. Pharmacodyn. 1979; 238: 220-32.
26. Cervero F. Sensory innervation of the viscera: Peripheral basis of visceral pain. Physiol. Rev. 1994; 74: 95-138.
27. Scharoun SL, Barone FC, Wayner MJ, Jones SM. Vagal and gastric connections to the central nervous system determined by the transport of horseradish peroxidase. Brain Res. Bull. 1984; 13: 573-83.
28. Lynn RB. Mechanisms of oesophageal pain. Am. J. Med. 1992; 92 (Suppl. 5A): 11-19.
29. Kamikawa Y, Shimo Y. Indirect action of 5-hydroxytryptamine on the isolated muscularis mucosae of the guinea-pig oesophagus. Br. J. Pharmacol. 1983; 78: 103-10.
30. Keast JR, Furness JB, Costa M. Distribution of certain peptide-containing nerve fibres and endocrine cells in the gastrointestinal mucosa in five mammalian species. J. Comp. Neurol. 1985; 236: 403-22.
31. Maggi CA, Meli A. The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen. Pharmacol. 1988; 19: 1-43.
32. Ross SB, Renyi AL. Inhibition of uptake of tritiated 5-hydroxytryptamine in brain tissue. Eur. J. Pharmacol. 1969; 7: 270-7.
33. Kerr KP, Mitchelson F, Coupar IM. Vagal nerve stimulation of the guinea-pig oesophagus. Acta Physiol. Scand. 1995; 154: 213-20.
34. Delbro D, Lisander B, Anderson SA. Bradykinin-induced atropine-sensitive gastric contractions. Activation of an intramural axon reflex? Acta Physiol. Scand. 1986; 127: 111-17.
35. Kerr KP, Mitchelson F, Coupar IM. Tachykinins play a minor role in mediating the third phase of the contractile response to vagal nerve stimulation of the guinea-pig oesophagus. Neuropeptides 2000; 34: 12-17.
36. Kerr KP, Mitchelson F, Coupar IM. Putative neurotransmitters in the mediation of a capsaicin-sensitive, hexamethonium-resistant cholinergic contractile response. Proc. Aust. Soc. Clin. Exp. Pharmacol. Toxicol. 1998; 5: P1-99 (Abstract).
37. Maggi CA. The pharmacology of the efferent function of sensory nerves. J. Auton. Pharmacol. 1991; 11: 173-208.
38. Bartho L, Lenard Jr L, Patacchini R, Halmai V, Wilhelm M, Holzer P. Tachykinin receptors are involved in the 'local efferent' motor response to capsaicin in the guinea-pig small intestine and oesophagus. Neuroscience 1999; 90: 221-8.
39. Barthó L, Koczan G, Maggi CA. Studies on the mechanism of the contractile action of rat calcitonin gene-related peptide and of capsaicin on the guinea-pig ileum. Effect of hCGRP(8-37) and CGRP tachyphylaxis. Neuropeptides 1993; 25: 325-9.
40. Williams JT, North RA. Vasoactive intestinal polypeptide excites neurones of the myenteric plexus. Brain Res. 1979; 175: 174-7.
41. Luzzi S, Zilletti L, Franchi-Micheli S, Gori AM, Moroni F. Agonists, antagonists and modulators of excitatory amino acid receptors in the guinea-pig myenteric plexus. Br. J. Pharmacol. 1988; 95: 1271-7.
42. Birmingham AT, Hussain SZ. A comparison of the skeletal neuromuscular and autonomic ganglion-blocking potencies of five non-depolarizing relaxants. Br. J. Pharmacol. 1980; 70: 501-6.
43. Bowman WC, Webb SN. Neuromuscular blocking and ganglion blocking activities of some acetylcholine antagonists in the cat. J. Pharm. Pharmacol. 1972; 24: 762-72.
44. Bowman WC, Webb SN. Tetanic fade during partial transmission failure produced by non-depolarizing neuromuscular blocking drugs in the cat. Clin. Exp. Pharmacol. Physiol. 1976; 3: 545-55.
45. Bowman WC, Marshall IG, Gibb AJ. Is there feedback control of transmitter release at the neuromuscular junction? Semin. Anesth. 1984; 3: 275-83.
46. Bowman WC, Marshall IG, Gibb AJ, Harborne AJ. Feedback control of transmitter release at the neuromuscular junction. Trends Pharmacol. Sci. 1988; 9: 16-20.
47. Gallacci M, Oliveira AC. Mechanisms of hexamethonium-induced tetanic fade in the isolated rat muscle. Arch. Int. Pharmacodyn. 1990; 305: 111-22.
48. Wilson DF, Thomsen RH. Nicotinic receptors on the rat phrenic nerve: Evidence for negative feedback. Neurosci. Lett. 1991; 132: 163-6.
49. Tian L, Prior C, Dempster J, Marshall IG. Nicotinic antagonist produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals. J. Physiol. 1994; 476: 517-29.
50. Regoli D, Drapeau G, Dion S, Couture P. New selective agonists for neurokinin receptors: Pharmacological tools for receptor characterization. Trends Pharmacol. Sci. 1988; 9: 290-5.
51. Kerr KP, Mitchelson F, Coupar IM. Tachykinin receptors in the guinea-pig oesophagus: A complex system. Br. J. Pharmacol. 1997; 120: 1021-8.
52. 2 receptors. Br. J. Pharmacol. 2000; 131: 1461-7.
53. De Luca A, Rand MJ, Reid JJ, Story DF. Differential sensitivities of avian and mammalian neuromuscular junctions to inhibition of cholinergic transmission by ω-conotoxin GVIA. Toxicon 1991; 29: 311-20.
54. Wright CE, Angus JA. Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission. Br. J. Pharmacol. 1996; 119: 49-56.
55. Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB. Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicks. Toxicon 1994; 32: 257-65.